XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:    
Net income including non-controlling interests $ 513,070 $ 599,153
Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:    
Depreciation, depletion and amortization 270,837 86,809
Gain on sale of assets (2,840) (520,740)
Impairment 28,964 0
Deferred income taxes 145,857 (7)
Net (gain) loss on derivative instruments (96,452) 466,175
Net (gain) loss from investment in unconsolidated affiliate (7,910) 36,116
Equity-based compensation expenses 27,181 9,663
Deferred financing costs amortization and other (4,035) 3,294
Working capital and other changes:    
Change in accounts receivable, net 5,564 (112,688)
Change in inventory (3,526) (14,040)
Change in prepaid expenses 317 1,035
Change in accounts payable, interest payable and accrued liabilities (11,084) 96,141
Change in other assets and liabilities, net 11,104 11,080
Net cash provided by operating activities 877,047 661,991
Cash flows from investing activities:    
Capital expenditures (407,773) (114,325)
Acquisitions (361,609) 0
Proceeds from divestitures, net of cash divested 59,219 148,818
Costs related to divestitures 0 (11,368)
Derivative settlements (154,110) (201,668)
Distributions from investment in unconsolidated affiliate 5,984 26,862
Net cash used in investing activities (858,289) (151,681)
Cash flows from financing activities:    
Proceeds from revolving credit facilities 0 15,000
Deferred financing costs 0 (9)
Repurchases of common stock (45,818) 0
Tax withholding on vesting of equity-based awards (13,631) (4,789)
Dividends paid (337,747) (139,860)
Payments on finance lease liabilities (933) (229)
Proceeds from warrants exercised 1,007 15,908
Net cash used in financing activities (397,122) (113,979)
Increase (decrease) in cash and cash equivalents (378,364) 396,331
Cash and cash equivalents:    
Beginning of period 593,151 174,783
End of period 214,787 571,114
Supplemental non-cash transactions:    
Change in accrued capital expenditures 74,114 (806)
Change in asset retirement obligations 547 (428)
Investment in unconsolidated affiliate 0 568,312
Dividends payable $ 35,321 $ 317,530